CRCL delivered its earnings release on Wednesday, and the initial pop has given way to a 3.8% pullback Tuesday, leaving the stock at $71.73 — a more complicated picture than the confident squeeze narrative of last week.
Short interest tells the clearest story of the week: bears are still there. SI has pulled back 9.2% over the past seven days to 11.65% of the free float, continuing the retreat flagged in recent notes, but that level remains elevated for a company this young and this recently public. The one-month trend complicates the picture further — shorts have actually built roughly 8.8% more exposure than a month ago, meaning last week's cover looks more like tactical trimming than genuine capitulation. The borrow market, meanwhile, has shifted notably. Availability has tightened from around 167% two weeks ago to 127% now — still in moderate territory, but the trend direction has reversed sharply, with availability down 15% on the week alone. The 52-week trough was near zero, so there is plenty of headroom before a mechanical squeeze, but the pace of tightening is worth watching. Cost to borrow has eased 20% on the week to 0.44%, the lowest reading in the 30-day window. Cheap borrow alongside tighter availability is an unusual combination — it suggests new shorts are not paying a premium to press the position, but fewer shares are circulating back into the lending pool.
Options positioning adds a mild contrarian data point. Call demand has risen relative to puts, with the put/call ratio at 0.72 — nearly two standard deviations below its 20-day average of 0.75 and close to a year-low lean toward calls. That is not a dramatic skew, but it does mean options traders are more bullish than they have been at almost any point in the past year, even as the stock has pulled back from its post-earnings high.
The Street remains divided in a way that maps directly onto CRCL's core tension. Bulls, including TD Cowen — which raised its target to $87 from $82 just last week while keeping a Buy — point to genuine operating scale: 72% year-over-year USDC circulation growth, nearly 50% transaction-volume market share, and $770 million in revenue with improving margins. Canaccord and Needham both trimmed targets after the print (to $130 and $127 respectively from higher levels), but held their Buy ratings — a signal that the Street still believes in the growth story, even if the near-term bar was punishing. Morgan Stanley, the sole Underweight, held firm at a $37 target, a long way below the current price and the consensus mean of $101. The P/E has expanded about 13 points over the past month to 48.8x, and the P/B has moved up roughly 0.9x, reflecting the post-IPO re-rating rather than pure earnings-driven multiple expansion.
Ownership data offers one more layer of nuance. Founder and CEO Jeremy Allaire remains the largest disclosed individual holder at 6.4% of shares. His August 5 sales were small in aggregate — roughly $1.3 million across multiple tranches — and likely reflect a pre-planned programme rather than directional conviction. More notable is the institutional flow: BlackRock added 3.3 million shares through July, State Street added 1.76 million, and Morgan Stanley Investment Management added 2.3 million — all net buyers into the same period when short interest was building. That institutional accumulation and high short interest coexisting at 11.65% of float is the structural tension that defines CRCL right now.
The next data point worth watching is how availability continues to evolve now that the earnings event has cleared — if tightening accelerates past the 100% level while SI remains sticky above 10%, the squeeze dynamic that began before the print re-enters the conversation.
See the live data behind this article on ORTEX.
Open CRCL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
